Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest acetanilides Stories

2012-07-19 06:26:00

OTTAWA, July 19, 2012 /CNW/ - For chinese version click here: http://files.newswire.ca/1043/Chinese.pdf The issue: "Vine Essence" has been recalled after testing by Health Canada identified a quantity of lead that exceeds Departmental acceptable limits and low levels of undeclared acetaminophen. Infants, young children, pregnant women and breastfeeding women are particularly at risk. Short-term exposure to lead may lead to vomiting, diarrhea, convulsions, coma or even death. While...

2012-06-25 06:32:10

MIAMI BEACH, Fla., June 25, 2012 /PRNewswire/ -- Divine Skin today announced that it was granted a Drug Enforcement Agency license in partnership with its manufacturing partner to produce and distribute Ephedrine containing drugs and other controlled substances. The Company has started working on a new OTC analgesic, which it believes could provide an alternative to current OTC pain relievers. Receiving this mandatory license is the final step in commencing manufacturing of its OTC pain...

2012-02-28 15:05:00

NASHVILLE, Tenn., Feb. 28, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced it has entered into an exclusive agreement with China's Harbin Gloria Pharmaceuticals Co., Ltd. (SHE: 002437)for the commercialization of Acetadote® (acetylcysteine), its injectable drug used to treat acetaminophen overdose, and Caldolor® (ibuprofen) Injection, which is used to treat pain and fever in the hospital setting. The agreement will provide Harbin Gloria...

2012-02-06 16:00:00

SAN DIEGO, Feb. 6, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today the voluntary recall of a single lot of OFIRMEV® (acetaminophen) injection. Cadence has notified the U.S. Food and Drug Administration of the recall. The recall of OFIRMEV lot number V005710 was initiated due to the presence of an...

FDA Warns Parents Of Confusing Acetaminophen Doses
2011-12-27 14:08:39

The Federal Drug Administration (FDA) is asking parents and caregivers to double check the label on liquid acetaminophen before giving it to a child or infant. The FDA asked guardians to be careful when reading the label on liquid acetaminophen marketed to infants and children as a new, less concentrated form of the popular pain reliever arrives on store shelves. A new 160 milligram per 5 milliliter concentration of acetaminophen is now available in drugstores, which is a more...

2011-11-23 11:33:25

Repeatedly taking slightly too much paracetamol over time can cause a dangerous overdose that is difficult to spot, but puts the person at danger of dying. Patients may not come to hospital reporting the overdose, but because they feel unwell. This clinical situation needs to be recognized and treated rapidly because these patients are at even greater danger than people who take single overdoses. These so-called staggered overdoses can occur when people have pain and repeatedly take a...

2011-11-03 15:00:00

SAN DIEGO, Nov. 3, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2011. For the third quarter of 2011, net sales of Cadence's product, OFIRMEV® (acetaminophen) injection, the first and only intravenous formulation of...

2011-09-19 07:15:00

IRVINGTON, N.Y., Sept. 19, 2011 /PRNewswire/ -- Acetaminophen is one of the most commonly used pain and fever relievers for infants and children and is safe and effective when used as directed. Now, dosing has been made even easier for parents and safer for children as the new PediaCare® and Little Remedies® single-concentration acetaminophen products hit store shelves. The new standard concentration liquid acetaminophen products for infants and...

2011-07-28 16:00:00

SAN DIEGO, July 28, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) today confirmed that the U.S. Food and Drug Administration (FDA) approved dosing recommendations for OFIRMEV® (acetaminophen) injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg. Cadence's announcement follows the issuance of a news release by a major manufacturer of over-the-counter (OTC) acetaminophen products announcing its plans to lower the...

2011-05-05 11:02:00

Move to one liquid concentration of these pediatric pain and fever reducers is the latest industry effort to help parents and caregivers avoid any potential dosing confusion WASHINGTON, May 5, 2011 /PRNewswire-USNewswire/ -- Today, the Consumer Healthcare Products Association (CHPA), representing the makers of over-the-counter (OTC) single-ingredient liquid pediatric acetaminophen medicines, announces plans to convert these pediatric products to just one concentration. While the...